Acquired resistance to endocrine treatments is associated with tumor-specific molecular changes in patient-derived luminal breast cancer xenografts. [electronic resource]
Producer: 20151013Description: 4314-25 p. digitalISSN:- 1557-3265
- Animals
- Antineoplastic Agents, Hormonal -- pharmacology
- Apoptosis -- drug effects
- Biomarkers, Tumor -- genetics
- Blotting, Western
- Breast Neoplasms -- drug therapy
- Cell Cycle -- drug effects
- Cell Proliferation -- drug effects
- Drug Resistance, Neoplasm
- Estrogen Receptor alpha -- genetics
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Immunoenzyme Techniques
- Mice
- Mice, Nude
- RNA, Messenger -- genetics
- Real-Time Polymerase Chain Reaction
- Receptor, ErbB-2 -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction
- Tamoxifen -- pharmacology
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.